Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection

Paola Cavalcante, Barbara Galbardi, Sara Franzi, Stefania Marcuzzo, Claudia Barzago, Silvia Bonanno, Giorgia Camera, Lorenzo Maggi, Dimos Kapetis, Francesca Andreetta, Amelia Biasiucci, Teresio Motta, Carmelo Giardina, Carlo Antozzi, Fulvio Baggi, Renato Mantegazza, Pia Bernasconi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Considerable data implicate the thymus as the main site of autosensitization to the acetylcholine receptor in myasthenia gravis (MG), a B-cell-mediated autoimmune disease affecting the neuromuscular junction. We recently demonstrated an active Epstein-Barr virus (EBV) infection in the thymus of MG patients, suggesting that EBV might contribute to the onset or maintenance of the autoimmune response within MG thymus, because of its ability to activate and immortalize autoreactive B cells. EBV has been reported to elicit and modulate Toll-like receptor (TLR) 7- and TLR9-mediated innate immune responses, which are known to favor B-cell dysfunction and autoimmunity. Aim of this study was to investigate whether EBV infection is associated with altered expression of TLR7 and TLR9 in MG thymus. By real-time PCR, we found that TLR7 and TLR9 mRNA levels were significantly higher in EBV-positive MG compared to EBV-negative normal thymuses. By confocal microscopy, high expression levels of TLR7 and TLR9 proteins were observed in B cells and plasma cells of MG thymic germinal centers (GCs) and lymphoid infiltrates, where the two receptors co-localized with EBV antigens. An increased frequency of Ki67-positive proliferating B cells was found in MG thymuses, where we also detected proliferating cells expressing TLR7, TLR9 and EBV antigens, thus supporting the idea that EBV-associated TLR7/9 signaling may promote abnormal B-cell activation and proliferation. Along with B cells and plasma cells, thymic epithelium, plasmacytoid dendritic cells and macrophages exhibited enhanced TLR7 and TLR9 expression in MG thymus; TLR7 was also increased in thymic myeloid dendritic cells and its transcriptional levels positively correlated with those of interferon (IFN)-β. We suggested that TLR7/9 signaling may be involved in antiviral type I IFN production and long-term inflammation in EBV-infected MG thymuses. Our overall findings indicate that EBV-driven TLR7- and TLR9-mediated innate immune responses may participate in the intra-thymic pathogenesis of MG.

Original languageEnglish
Pages (from-to)516-527
Number of pages12
JournalImmunobiology
Volume221
Issue number4
DOIs
Publication statusPublished - Apr 1 2016

Fingerprint

Toll-Like Receptor 7
Toll-Like Receptor 9
Epstein-Barr Virus Infections
Myasthenia Gravis
Thymus Gland
Human Herpesvirus 4
B-Lymphocytes
Plasma Cells
Autoimmunity
Innate Immunity
Dendritic Cells
Antigens
Interferon Type I
Germinal Center
Neuromuscular Junction
Cholinergic Receptors
Myeloid Cells
Confocal Microscopy
Interferons
Autoimmune Diseases

Keywords

  • Epstein-Barr virus
  • Myasthenia gravis
  • Thymus
  • Toll-like receptor 7
  • Toll-like receptor 9

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Hematology

Cite this

Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection. / Cavalcante, Paola; Galbardi, Barbara; Franzi, Sara; Marcuzzo, Stefania; Barzago, Claudia; Bonanno, Silvia; Camera, Giorgia; Maggi, Lorenzo; Kapetis, Dimos; Andreetta, Francesca; Biasiucci, Amelia; Motta, Teresio; Giardina, Carmelo; Antozzi, Carlo; Baggi, Fulvio; Mantegazza, Renato; Bernasconi, Pia.

In: Immunobiology, Vol. 221, No. 4, 01.04.2016, p. 516-527.

Research output: Contribution to journalArticle

Cavalcante, Paola ; Galbardi, Barbara ; Franzi, Sara ; Marcuzzo, Stefania ; Barzago, Claudia ; Bonanno, Silvia ; Camera, Giorgia ; Maggi, Lorenzo ; Kapetis, Dimos ; Andreetta, Francesca ; Biasiucci, Amelia ; Motta, Teresio ; Giardina, Carmelo ; Antozzi, Carlo ; Baggi, Fulvio ; Mantegazza, Renato ; Bernasconi, Pia. / Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection. In: Immunobiology. 2016 ; Vol. 221, No. 4. pp. 516-527.
@article{8491b52e17a84a91a7023a3b371b5ac5,
title = "Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection",
abstract = "Considerable data implicate the thymus as the main site of autosensitization to the acetylcholine receptor in myasthenia gravis (MG), a B-cell-mediated autoimmune disease affecting the neuromuscular junction. We recently demonstrated an active Epstein-Barr virus (EBV) infection in the thymus of MG patients, suggesting that EBV might contribute to the onset or maintenance of the autoimmune response within MG thymus, because of its ability to activate and immortalize autoreactive B cells. EBV has been reported to elicit and modulate Toll-like receptor (TLR) 7- and TLR9-mediated innate immune responses, which are known to favor B-cell dysfunction and autoimmunity. Aim of this study was to investigate whether EBV infection is associated with altered expression of TLR7 and TLR9 in MG thymus. By real-time PCR, we found that TLR7 and TLR9 mRNA levels were significantly higher in EBV-positive MG compared to EBV-negative normal thymuses. By confocal microscopy, high expression levels of TLR7 and TLR9 proteins were observed in B cells and plasma cells of MG thymic germinal centers (GCs) and lymphoid infiltrates, where the two receptors co-localized with EBV antigens. An increased frequency of Ki67-positive proliferating B cells was found in MG thymuses, where we also detected proliferating cells expressing TLR7, TLR9 and EBV antigens, thus supporting the idea that EBV-associated TLR7/9 signaling may promote abnormal B-cell activation and proliferation. Along with B cells and plasma cells, thymic epithelium, plasmacytoid dendritic cells and macrophages exhibited enhanced TLR7 and TLR9 expression in MG thymus; TLR7 was also increased in thymic myeloid dendritic cells and its transcriptional levels positively correlated with those of interferon (IFN)-β. We suggested that TLR7/9 signaling may be involved in antiviral type I IFN production and long-term inflammation in EBV-infected MG thymuses. Our overall findings indicate that EBV-driven TLR7- and TLR9-mediated innate immune responses may participate in the intra-thymic pathogenesis of MG.",
keywords = "Epstein-Barr virus, Myasthenia gravis, Thymus, Toll-like receptor 7, Toll-like receptor 9",
author = "Paola Cavalcante and Barbara Galbardi and Sara Franzi and Stefania Marcuzzo and Claudia Barzago and Silvia Bonanno and Giorgia Camera and Lorenzo Maggi and Dimos Kapetis and Francesca Andreetta and Amelia Biasiucci and Teresio Motta and Carmelo Giardina and Carlo Antozzi and Fulvio Baggi and Renato Mantegazza and Pia Bernasconi",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.imbio.2015.12.007",
language = "English",
volume = "221",
pages = "516--527",
journal = "Immunobiology",
issn = "0171-2985",
publisher = "Urban und Fischer Verlag GmbH und Co. KG",
number = "4",

}

TY - JOUR

T1 - Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection

AU - Cavalcante, Paola

AU - Galbardi, Barbara

AU - Franzi, Sara

AU - Marcuzzo, Stefania

AU - Barzago, Claudia

AU - Bonanno, Silvia

AU - Camera, Giorgia

AU - Maggi, Lorenzo

AU - Kapetis, Dimos

AU - Andreetta, Francesca

AU - Biasiucci, Amelia

AU - Motta, Teresio

AU - Giardina, Carmelo

AU - Antozzi, Carlo

AU - Baggi, Fulvio

AU - Mantegazza, Renato

AU - Bernasconi, Pia

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Considerable data implicate the thymus as the main site of autosensitization to the acetylcholine receptor in myasthenia gravis (MG), a B-cell-mediated autoimmune disease affecting the neuromuscular junction. We recently demonstrated an active Epstein-Barr virus (EBV) infection in the thymus of MG patients, suggesting that EBV might contribute to the onset or maintenance of the autoimmune response within MG thymus, because of its ability to activate and immortalize autoreactive B cells. EBV has been reported to elicit and modulate Toll-like receptor (TLR) 7- and TLR9-mediated innate immune responses, which are known to favor B-cell dysfunction and autoimmunity. Aim of this study was to investigate whether EBV infection is associated with altered expression of TLR7 and TLR9 in MG thymus. By real-time PCR, we found that TLR7 and TLR9 mRNA levels were significantly higher in EBV-positive MG compared to EBV-negative normal thymuses. By confocal microscopy, high expression levels of TLR7 and TLR9 proteins were observed in B cells and plasma cells of MG thymic germinal centers (GCs) and lymphoid infiltrates, where the two receptors co-localized with EBV antigens. An increased frequency of Ki67-positive proliferating B cells was found in MG thymuses, where we also detected proliferating cells expressing TLR7, TLR9 and EBV antigens, thus supporting the idea that EBV-associated TLR7/9 signaling may promote abnormal B-cell activation and proliferation. Along with B cells and plasma cells, thymic epithelium, plasmacytoid dendritic cells and macrophages exhibited enhanced TLR7 and TLR9 expression in MG thymus; TLR7 was also increased in thymic myeloid dendritic cells and its transcriptional levels positively correlated with those of interferon (IFN)-β. We suggested that TLR7/9 signaling may be involved in antiviral type I IFN production and long-term inflammation in EBV-infected MG thymuses. Our overall findings indicate that EBV-driven TLR7- and TLR9-mediated innate immune responses may participate in the intra-thymic pathogenesis of MG.

AB - Considerable data implicate the thymus as the main site of autosensitization to the acetylcholine receptor in myasthenia gravis (MG), a B-cell-mediated autoimmune disease affecting the neuromuscular junction. We recently demonstrated an active Epstein-Barr virus (EBV) infection in the thymus of MG patients, suggesting that EBV might contribute to the onset or maintenance of the autoimmune response within MG thymus, because of its ability to activate and immortalize autoreactive B cells. EBV has been reported to elicit and modulate Toll-like receptor (TLR) 7- and TLR9-mediated innate immune responses, which are known to favor B-cell dysfunction and autoimmunity. Aim of this study was to investigate whether EBV infection is associated with altered expression of TLR7 and TLR9 in MG thymus. By real-time PCR, we found that TLR7 and TLR9 mRNA levels were significantly higher in EBV-positive MG compared to EBV-negative normal thymuses. By confocal microscopy, high expression levels of TLR7 and TLR9 proteins were observed in B cells and plasma cells of MG thymic germinal centers (GCs) and lymphoid infiltrates, where the two receptors co-localized with EBV antigens. An increased frequency of Ki67-positive proliferating B cells was found in MG thymuses, where we also detected proliferating cells expressing TLR7, TLR9 and EBV antigens, thus supporting the idea that EBV-associated TLR7/9 signaling may promote abnormal B-cell activation and proliferation. Along with B cells and plasma cells, thymic epithelium, plasmacytoid dendritic cells and macrophages exhibited enhanced TLR7 and TLR9 expression in MG thymus; TLR7 was also increased in thymic myeloid dendritic cells and its transcriptional levels positively correlated with those of interferon (IFN)-β. We suggested that TLR7/9 signaling may be involved in antiviral type I IFN production and long-term inflammation in EBV-infected MG thymuses. Our overall findings indicate that EBV-driven TLR7- and TLR9-mediated innate immune responses may participate in the intra-thymic pathogenesis of MG.

KW - Epstein-Barr virus

KW - Myasthenia gravis

KW - Thymus

KW - Toll-like receptor 7

KW - Toll-like receptor 9

UR - http://www.scopus.com/inward/record.url?scp=84963705961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963705961&partnerID=8YFLogxK

U2 - 10.1016/j.imbio.2015.12.007

DO - 10.1016/j.imbio.2015.12.007

M3 - Article

AN - SCOPUS:84963705961

VL - 221

SP - 516

EP - 527

JO - Immunobiology

JF - Immunobiology

SN - 0171-2985

IS - 4

ER -